Skip to main content

Avanza Fonder AB

SEC CIK
0002035325
Latest filing
Jul 17, 2026

The latest 13F from Avanza Fonder AB covers Q2 2026 (filed Jul 17, 2026): 458 long positions worth $4.59B. The top 10 holdings make up 38.8% of the portfolio, and the largest is Apple Inc. (AAPL) at 7.0%. Livermore has 7 filings on Form 13F from this institution, going back to Q4 2024.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
11
Est. +$9.21M
Added
246
Est. +$479.0M
Reduced
49
Est. −$41.7M
Sold out
37
Est. −$33.9M

Top 5 holdings

Share of this quarter's portfolio value

  1. AAPLApple Inc.
    7.0%$322.5MHistory
  2. NVDANVIDIA Corp
    7.0%$319.4MHistory
  3. MSFTMicrosoft Corp
    4.7%$214.6MHistory
  4. AMZNAmazon Com Inc
    4.4%$201.2MHistory
  5. GOOGLAlphabet Inc.
    3.5%$162.9MHistory

Share of portfolio

Top 5 holdings and the other 453 positions, by share of portfolio value

  1. AAPL7.0%
  2. NVDA7.0%
  3. MSFT4.7%
  4. AMZN4.4%
  5. GOOGL3.5%
  6. Other 453 positions73.4%

Biggest buys

New and added positions, by estimated amount bought

  1. MSFTMicrosoft Corp
    +$33.3MAddedHistory
  2. AMZNAmazon Com Inc
    +$31.1MAddedHistory
  3. AAPLApple Inc.
    +$28.3MAddedHistory
  4. NVDANVIDIA Corp
    +$26.4MAddedHistory
  5. AVGOBroadcom Inc.
    +$26.3MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. MUMicron Technology Inc
    +1.67 pp0.8% → 2.5%History
  2. AMDAdvanced Micro Devices Inc
    +1.31 pp0.9% → 2.2%History
  3. LRCXLam Research Corp
    +0.52 pp0.7% → 1.2%History
  4. AVGOBroadcom Inc.
    +0.50 pp1.8% → 2.3%History
  5. AMATApplied Materials Inc
    +0.50 pp0.7% → 1.2%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. MRVLMarvell Technology, Inc.
    −$4.83MReducedHistory
  2. PNRPENTAIR plc
    −$3.39MSold outHistory
  3. MCKMcKesson Corp
    −$2.91MReducedHistory
  4. TRIThomson Reuters Corp
    −$2.12MSold outHistory
  5. UNHUnitedHealth Group Inc
    −$1.91MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. ABTAbbott Laboratories
    −0.18 pp0.6% → 0.4%History
  2. MCKMcKesson Corp
    −0.16 pp0.3% → 0.2%History
  3. MDTMedtronic plc
    −0.12 pp0.3% → 0.2%History
  4. LOWLowes Companies Inc
    −0.10 pp0.4% → 0.3%History
  5. ZTSZoetis Inc.
    −0.10 pp0.2% → 0.1%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$4.59B
+$978.7M (+27.1%) vs. prior quarter
Positions
458
−26 vs. prior quarter
Top 10 concentration
38.8%
Top 10 as share of value
Turnover
1.8%
Q2 2026, one quarter
Average holding period
6.6 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2024), so positions held before then are understated.

13F filings by quarter

7 quarters, going back to Q4 2024. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $4.59B (Q2 2026)

Q4 2024: $3.37BQ1 2025: $3.05BQ2 2025: $3.38BQ3 2025: $3.86BQ4 2025: $3.94BQ1 2026: $3.61BQ2 2026: $4.59B
Q4 2024Q2 2026
13F filings of Avanza Fonder AB by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Jul 17, 2026458$4.59BAAPLNVDAMSFTvs. Q1 2026SEC
Q1 2026Apr 15, 2026484$3.61BAAPLNVDAMSFTvs. Q4 2025SEC
Q4 2025Jan 12, 2026497$3.94BNVDAAAPLMSFTvs. Q3 2025SEC
Q3 2025Oct 16, 2025428$3.86BNVDAAAPLMSFTvs. Q2 2025SEC
Q2 2025Jul 14, 2025433$3.38BNVDAAAPLMSFTvs. Q1 2025SEC
Q1 2025Apr 15, 2025460$3.05BAAPLNVDAMSFTvs. Q4 2024SEC
Q4 2024Jan 15, 2025437$3.37BAAPLNVDAMSFT–SEC